Comparative study between pirfenidone and traditional drugs in treatment of idiopathic pulmonary fibrosis
Background Idiopathic pulmonary fibrosis (IPF) is a specific fibrosing form of interstitial pneumonia that is chronic, progressive and of an unknown etiology. IPF was initially considered to be an inflammation-driven disorder. Therefore, early treatment is aimed to eliminate or suppress the inflamma...
Main Authors: | Ramadan M Nafee, Waheed M Shoman, Mohammed M.N AboZaid, Dalia A El Wahed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Egyptian Journal of Chest Disease and Tuberculosis |
Subjects: | |
Online Access: | http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2019;volume=68;issue=2;spage=245;epage=251;aulast=Nafee |
Similar Items
-
Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study
by: Myung Jin Song, et al.
Published: (2021-05-01) -
Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
by: Goran Nadir Salih, et al.
Published: (2016-09-01) -
Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
by: Argyrios Tzouvelekis, et al.
Published: (2017-11-01) -
Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
by: Gareth Hughes, et al.
Published: (2016-09-01) -
Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
by: Argyrios Tzouvelekis, et al.
Published: (2018-01-01)